Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"

Affiliations

¹ Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Germany (C.W.).
² Cardio-Metabolic Medicine, Boehringer Ingelheim International GmbH, Germany (M.v.E.).
³ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Canada (B.Z.).

Comment

Christoph Wanner et al. Circulation. 2018.

. 2018 Aug 21;138(8):850-851.

doi: 10.1161/CIRCULATIONAHA.118.035881.

¹ Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Germany (C.W.).
² Cardio-Metabolic Medicine, Boehringer Ingelheim International GmbH, Germany (M.v.E.).
³ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Canada (B.Z.).

No abstract available

Comment on

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, Woerle HJ, Broedl UC, von Eynatten M, Zinman B; EMPA-REG OUTCOME Investigators. Wanner C, et al. Circulation. 2018 Jan 9;137(2):119-129. doi: 10.1161/CIRCULATIONAHA.117.028268. Epub 2017 Sep 13. Circulation. 2018. PMID: 28904068 Clinical Trial.
Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
Koh KK. Koh KK. Circulation. 2018 Aug 21;138(8):846-847. doi: 10.1161/CIRCULATIONAHA.118.033867. Circulation. 2018. PMID: 30359121 No abstract available.
Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
Tampakis A, Tampaki EC, Gürke L. Tampakis A, et al. Circulation. 2018 Aug 21;138(8):848-849. doi: 10.1161/CIRCULATIONAHA.117.032720. Circulation. 2018. PMID: 30359125 No abstract available.